AbstractMATERIALS AND METHODS: We examined pretreatment magnetic resonance imaging (MRI) examinations from 32 patients with glioblastoma multiforme (GBM) enrolled in The Cancer Genome Atlas (TCGA). Spatial variations in T1 post-gadolinium and either T2-weighted or fluid attenuated inversion recovery sequences from each tumor MRI study were used to characterize each small region of the tumor by its local contrast enhancement and edema/cellularity (“habitat”). The patient cohort was divided into group 1 (survival < 400 days, n = 16) and group 2 (survival > 400 days, n = 16). RESULTS: Histograms of relative values in each sequence demonstrated that the tumor regions were consistently divided into high and low blood contrast enhancement, each o...
Introduction Glioblastoma is characterized by its remarkable heterogeneity and dismal prognosis. His...
Objective: To develop and validate a volume-based, quantitative imaging marker by integrating multi...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Background. Glioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comp...
<div><p>One of the most common and aggressive malignant brain tumors is Glioblastoma multiforme. Des...
Intratumor heterogeneity is partly responsible for the poor prognosis of glioblastoma (GBM) patients...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Glioblastoma multiforme (GBM) is an aggressive form of human brain cancer that is under active study...
Glioblastoma, the most common and deadly form of primary brain cancer, is characterized by rapid pro...
AbstractBackground and purposeIn treating glioblastoma (GB), surgical and chemotherapeutic treatment...
Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis an...
Background Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. GBM remain...
Background: Glioblastoma is the most aggressive type of brain cancer with high-levels of intra- and ...
Glioblastoma is a high-grade aggressive neoplasm characterised by significant intra-tumoral spatial ...
Objective To determine the predictive value of median relative cerebral blood volume (rCBVmedian) of...
Introduction Glioblastoma is characterized by its remarkable heterogeneity and dismal prognosis. His...
Objective: To develop and validate a volume-based, quantitative imaging marker by integrating multi...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Background. Glioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comp...
<div><p>One of the most common and aggressive malignant brain tumors is Glioblastoma multiforme. Des...
Intratumor heterogeneity is partly responsible for the poor prognosis of glioblastoma (GBM) patients...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
Glioblastoma multiforme (GBM) is an aggressive form of human brain cancer that is under active study...
Glioblastoma, the most common and deadly form of primary brain cancer, is characterized by rapid pro...
AbstractBackground and purposeIn treating glioblastoma (GB), surgical and chemotherapeutic treatment...
Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis an...
Background Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. GBM remain...
Background: Glioblastoma is the most aggressive type of brain cancer with high-levels of intra- and ...
Glioblastoma is a high-grade aggressive neoplasm characterised by significant intra-tumoral spatial ...
Objective To determine the predictive value of median relative cerebral blood volume (rCBVmedian) of...
Introduction Glioblastoma is characterized by its remarkable heterogeneity and dismal prognosis. His...
Objective: To develop and validate a volume-based, quantitative imaging marker by integrating multi...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...